Growth Metrics

SS Innovations International (SSII) Share-based Compensation (IS) (2023 - 2024)

SS Innovations International recorded quarterly Share-based Compensation (IS) of $5.2 million in Q1 2024, down 46.63% quarter-over-quarter from $9.7 million in Q4 2023, and up 224.78% year-over-year from $1.6 million in Q2 2023.

SS Innovations International's Share-based Compensation (IS) history runs 2 years deep, the most recent figure standing at $5.2 million for Q1 2024.

  • In Q1 2024, Share-based Compensation (IS) rose 224.78% year-over-year to $5.2 million; the TTM figure through Mar 2024 stood at $14.9 million (changed N/A YoY), while the FY2023 annual figure was $9.7 million, up 756.34% from the prior year.
  • Share-based Compensation (IS) came in at $5.2 million for Q1 2024 at SS Innovations International, down from $9.7 million in the prior quarter.
  • In the past five years, Share-based Compensation (IS) ranged from a high of $9.7 million in Q4 2023 to a low of $8150.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (IS) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 35.12 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 SS Innovations International 770.31 Mn 746.70 Mn 5.33 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2024 5.17 Mn
Mar 31, 2024 5.17 Mn
Dec 31, 2023 9.69 Mn
Dec 31, 2023 9.69 Mn
Sep 30, 2023 24,450.00
Sep 30, 2023 24,450.00
Jun 30, 2023 8,150.00
Jun 30, 2023 8,150.00
Mar 31, 2023 1.59 Mn
Mar 31, 2023 1.59 Mn